对话分析
宏观分析
个别股票
Alpha 实验室
实用工具
Menu
ZH
登录
ZH
暴涨分析
/
TiumBio Co., Ltd.
/
2026-04-23
▲ SURGE
TiumBio Co., Ltd.
+14.4%
321550
KRX
Healthcare
2026-04-23
10,560
收盘价
9,230
前收盘价
+14.41%
涨幅
3.1x
量比
暴涨原因
没有相关新闻。
相关新闻
Uni-Bio Science to Update Articles for New HK Listing and Market Regimes
Tipranks
2026-03-27
Lithium Energy Trading Reinstated on ASX After Disclosure Update
Tipranks
2026-03-15
리가켐바이오 주가, 4월 20일 장중 202,000원 2.33% 상승
joongangenews
2026-04-20
Osteopore Issues Additional Unquoted Convertible Notes
Tipranks
2026-02-06
INmune Bio shares are trading higher after the company said it formally submitted its pre-submission package for CORDStrom with the UK's Medicines and Healthcare Products Regulatory Agency. - INmune Bio (NASDAQ:INMB)
Benzinga
2026-02-10
技术分析
信号
MACD看跌
站上SMA20
关键指标
56.71
RSI (14)
10500.00
SMA 20
8250.79
Bollinger Lower
12749.21
Bollinger Upper
10500.00
Bollinger Mid
111.33
MACD
282.23
MACD Signal
-170.90
MACD Hist
查看股票详情
返回暴涨股列表
TiumBio Co., Ltd. +14.4% 暴涨分析 (2026-04-23) | Alpha Lenz